Inventiva Secures EUR 21.4 Mln, Seals First Tranche Of Multi-Tranche Financing

T-Reuters

2024/12/16

Inventiva SA :Secures €21.4 Million And Completes The First Tranche Of The Previously Announced Multi-Tranche Financing Of Up To €348 Million.Additional Cash Requirements Estimated At €120 Million To €130 Million.Proceeds To Advance Phase Iii Nativ3 Clinical Trial.Appoints Mark Pruzanski As Chairman And Srinivas Akkaraju To Board.Company Estimates Financing Operations Until Mid-Q3 2025.Net Proceeds Of €20.1 Million To Fund Clinical Program And Corporate Purposes.Board Approves Second Phase Of Tranche 1 For €21.4 Million.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2491365173"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2491365173\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2491365173?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-16 15:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2491365173","market":"hk","top_or_hot":-1,"title":"Inventiva Secures EUR 21.4 Mln, Seals First Tranche Of Multi-Tranche Financing","media":"T-Reuters","content":"<html><body><p>Inventiva SA <ivaa.pa>:Secures €21.4 Million And Completes The First Tranche Of The Previously Announced Multi-Tranche Financing  Of Up To €348 Million.Additional Cash Requirements Estimated At €120 Million To €130 Million.Proceeds To Advance Phase Iii Nativ3 Clinical Trial.Appoints Mark Pruzanski As Chairman And Srinivas Akkaraju To Board<a href=\"https://laohu8.com/S/02403\">.C</a>ompany Estimates Financing Operations Until Mid-Q3 2025.Net Proceeds Of €20.1 Million To Fund Clinical Program And Corporate Purposes.Board Approves Second Phase Of Tranche 1 For €21.4 Million.</ivaa.pa></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Inventiva Secures EUR 21.4 Mln, Seals First Tranche Of Multi-Tranche Financing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInventiva Secures EUR 21.4 Mln, Seals First Tranche Of Multi-Tranche Financing\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time smaller\">2024-12-16 15:59</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p>Inventiva SA <ivaa.pa>:Secures €21.4 Million And Completes The First Tranche Of The Previously Announced Multi-Tranche Financing  Of Up To €348 Million.Additional Cash Requirements Estimated At €120 Million To €130 Million.Proceeds To Advance Phase Iii Nativ3 Clinical Trial.Appoints Mark Pruzanski As Chairman And Srinivas Akkaraju To Board<a href=\"https://laohu8.com/S/02403\">.C</a>ompany Estimates Financing Operations Until Mid-Q3 2025.Net Proceeds Of €20.1 Million To Fund Clinical Program And Corporate Purposes.Board Approves Second Phase Of Tranche 1 For €21.4 Million.</ivaa.pa></p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://www.trkd.thomsonreuters.com","article_id":"2491365173","we_media_id":"1086160438","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2491365173","pubTimestamp":1734335980,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"T-Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"summary":"Inventiva SA :Secures 21.4 Million And Completes The First Tranche Of The Previously Announced Multi-Tranche Financing  Of Up To 348 Million.Additional Cash Requirements Estimated At 120 Million To 130 Million.Proceeds To Advance Phase Iii Nativ3 Clinical Trial.Appoints Mark Pruzanski As Chairman And Srinivas Akkaraju To Board.Company Estimates Financing Operations Until Mid-Q3 2025.Net Proceeds Of 20.1 Million To Fund Clinical Program And Corporate Purposes.Board Approves Second Phase Of Tranche 1 For 21.4 Million.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","IVA":"Inventiva S.A."},"translate_title":"Inventiva获得2140万欧元，完成第一笔多笔融资","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IVA":0.9},"content_text":"Inventiva SA :Secures €21.4 Million And Completes The First Tranche Of The Previously Announced Multi-Tranche Financing  Of Up To €348 Million.Additional Cash Requirements Estimated At €120 Million To €130 Million.Proceeds To Advance Phase Iii Nativ3 Clinical Trial.Appoints Mark Pruzanski As Chairman And Srinivas Akkaraju To Board.Company Estimates Financing Operations Until Mid-Q3 2025.Net Proceeds Of €20.1 Million To Fund Clinical Program And Corporate Purposes.Board Approves Second Phase Of Tranche 1 For €21.4 Million.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}